Press esc to close search
Daily Market Updates, in bite-sized chunks.
Information unfiltered and straight from the source.
We cut through the bull and the bear to provide simple, engaging content for everyone.
Looking for a new idea, our investing ideas section is just what you’re looking for.
Our reports are packed full of unrivalled insight and analysis across a wide range of topics, industries and companies.
Our education section provides in-depth guides and articles across a range of topics.
Our glossary is a great place to start if you’re new to the world of investing.
Sign-Ups For Novo Nordisk's Weight Loss Drug Soar In US
Novo Nordisk's weight loss drug Wegovy experiences booming sign-ups in the US, while facing pricing pressures and emerging competition.
ALT Stock Short Report Raises Concerns over Altimmune's Weight-Loss Drug
Altimmune Inc. faces disappointment with its weight-loss drug, leading to a 19% stock drop. What does this mean for retail investors? Find out here.
Investors Watch as Novo Nordisk Pours Billions into Obesity Drugs
Novo Nordisk invests $2.3 billion in France to expand its weight-loss drug production, marking a significant move in the pharmaceutical industry.
